ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer?

Ziming Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.